Yong Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yong Sun has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Fayin Li
Department of Anesthesiology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, 223300, PR China
1 shared publicationFei Xu
Department of Neurology, Sichuan Medical Science Institute & Sichuan Provincial Hospital, Chengdu 610072, China
1 shared publicationHongling Li
Department of Radiotherapy, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai 201620, China
1 shared publicationJiayu Wang
Department of Anesthesiology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, 223300, PR China
1 shared publicationLin Li
Department of Anesthesiology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, 223300, PR China
1 shared publicationLin Yang
Department of Clinical Laboratory, Hubei Maternal and Child Health Hospital, Wuhan 430070, China
1 shared publication
Latest Publications
- 1 September 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 503 (4) , 2451-2458
The miR-31-SOX10 axis regulates tumor growth and chemotherapy resistance of melanoma via PI3K/AKT pathway
- 1 September 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 503 (4) , 2451-2458
The miR-31-SOX10 axis regulates tumor growth and chemotherapy resistance of melanoma via PI3K/AKT pathway
- 1 November 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 454 (4) , 566-571
Inhibition of Axl improves the targeted therapy against ALK-mutated neuroblastoma
- 1 November 2014
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 454 (4) , 566-571
Inhibition of Axl improves the targeted therapy against ALK-mutated neuroblastoma